Sysmex Continues to Evolve Its Hematology Product Portfolio
Since its founding in 1968, Sysmex has developed its business by focusing on the hematology field (blood cell count tests), which analyzes the number, type, and size of red and white blood cells as well as platelets. Sysmex has adopted a modular concept since the launch of the XN-Series Automated Hematology Analyzer (“XN-Series”) in 2011, combining modules for blood count, smear preparation, automated digital cell morphology analysis and sample sorting to offer a broad range of system options tailored to each customer’s environment, and has captured the largest market share worldwide
Sysmex continues to evolve its product portfolio in the field of hematology with the aim of “providing more valuable test results and creating a laboratory environment that can make the best use of these results.” To begin, Sysmex will launch its next-generation flagship model in the hematology field, the XR-Series Automated Hematology Analyzer (“XR-Series”) and a compact 3-part WBC differential model, the XQ-Series Automated Hematology Analyzer (“XQ-Series”).
The XR-Series, the successor to the XN-Series, was developed based on the following three pillars of “Operational Value (improvement in the efficiency of laboratory operations),” “Managerial Value (optimization of testing laboratory management),” and “Clinical Value (enhancing the clinical value of laboratory results).” In addition to improving the throughput by up to 10%, the XR-Series reduces the number of microscopy examinations required and improves the efficiency of laboratory operations by optimizing the counting of immature granulocytes1 and immature platelets, as well as optimizing the flagging function.2 Inheriting the modular concept, the XR-Series can be combined with modules for smear preparation, automatic digital cell morphology analysis, and sample sorting and archive, providing medium- to large-scale hospitals and clinical laboratories with a wide range of options. Sysmex will first introduce the XR-1000/XR-2000 models and then gradually expand products and services.
The XQ-Series, the successor to the XP-Series Automated Hematology Analyzer, has increased throughput to 70 tests per hour and improved the efficiency of laboratory operations by enhancing the differential WBC count performance through digital waveform processing. We have also adopted the technology of our flagship model and employed a highly robust, maintainable interface that is compatible with high-end instrument. By doing this, we aim to increase our market share and our presence in the market for 3-part WBC differential analyzers, particularly in emerging countries.
By connecting these two products with CaresphereTM, customers can easily and remotely monitor and analyze the operational status of their instrument and the entire laboratory, thereby further improving the efficiency of day-to-day laboratory operations. As a front-runner, Sysmex will strive to provide new value by proactively utilizing advanced technologies and continuously engaging in research and development.